Health ❯ Vaccines ❯ mRNA Vaccines

COVID-19 Vaccines

Safety Concerns Vaccine Development Public Health Policy Effectiveness Vaccine Efficacy Research and Development FDA Approval US Health Policy Efficacy and Safety Moderna Funding Delivery Methods DNA Integration Safety and Efficacy Contaminants Funding Cuts Development and Research BA.3.2 Vaccine Efficacy Safety Public Health Implications

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

Scientists and former health leaders say the reversal undermines rapid vaccine readiness and risks ceding biotech leadership abroad.

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

HHS Withdraws $500 Million for mRNA Vaccine Research as Experts Warn of Pandemic Risks

Trump Administration Cuts Moderna Funding and Disbands mRNA Vaccine Panel